Streetbeat News

Products Services

CHTR

PARA

Charter Communications will make Paramount's direct-to-consumer products available for purchase by its internet-only customers. This partnership aims to expand the reach of Paramount's streaming services and provide more options for Charter's customers.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:39 pm

CHTR

PARA

Paramount Global and Charter Communications have extended their partnership with a multi-year distribution agreement. Key points include continued carriage of Paramount's CBS stations and cable networks, and the inclusion of Paramount+ Essential and BET+ Essential at no additional cost to Spectrum TV Select packages and Mi Plan Latino customers.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:38 pm

LLY

Eli Lilly announced that it will present data from studies of Verzenio, Retevmo, olomorasib, and imlunestrant at the ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:35 pm

CADL

Candel Therapeutics is set to present data from its Phase 2 clinical trial of CAN-2409 at the American Society of Clinical Oncology (ASCO). The treatment has shown a favorable safety and tolerability profile in non-small cell lung cancer (NSCLC) as of the data cut-off date.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:32 pm

MURA

Mural Oncology shared data from the ARTISTRY-3 trial, which evaluated the effects of less frequent intravenous dosing of Nemvaleukin Alfa. The trial demonstrated pharmacodynamic proof of mechanism and showed that Nemvaleukin was generally well-tolerated at all doses tested.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:30 pm

NFLX

Netflix Inc (NASDAQ:NFLX) released its biannual engagement report, revealing that viewers watched over 90 billion hours of content from July to December 2023. Original content like 'Lupin,' 'The Witcher,' and 'The Crown' dominated viewership, while non-English content also performed well. The report highlights Netflix's strong performance and increased investment in foreign language media.

Portfolio Pulse from Hayden Buckfire

May 23, 2024 | 9:29 pm

BITW

BLK

ETHUSD

GBTC

The SEC has approved the first spot Ethereum ETFs, a move expected to boost mainstream adoption of cryptocurrency. Major financial institutions like BlackRock, Grayscale, and Bitwise are among those who filed for these ETFs. This approval is anticipated to attract significant institutional investment into Ethereum, potentially driving up its market value.

Portfolio Pulse from Murtuza Merchant

May 23, 2024 | 9:28 pm

THTX

Theratechnologies announced that their drug sudocetaxel zendusortide showed signs of long-term efficacy and a manageable safety profile in patients with solid tumors, according to an updated analysis from an ongoing Phase 1 clinical trial. The drug induced durable disease stabilization lasting up to 45 weeks beyond treatment completion.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:27 pm

KYMR

Kymera Therapeutics plans to present new clinical data from its ongoing Phase 1 trial of MDM2 degrader KT-253 at the ASCO meeting. The company will also share its biomarker-based patient selection strategy and future development steps.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:24 pm

EPRX

Eupraxia Pharmaceuticals announced that regulators in Australia and Canada have approved the expansion of its Phase 1b/2a Resolve trial.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 9:23 pm